#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Squamous cell carcinoma of the cervix Cutaneous lupus erythematosus Congenital nephrogenic diabetes insipidus Glycogen storage disease type II Mantle cell lymphoma Desmoplastic small round cell tumour Synovitis Erythema Anaplastic large cell lymphoma T- and null-cell types Metastatic malignant melanoma Hyperoxaluria Colon cancer Inflammatory myofibroblastic tumour Acute myeloid leukaemia (in remission) Proteus syndrome More trials…

    Learn about Rare Diseases

    Primary mediastinal large B-cell lymphoma Von Willebrand’s disease – Life with Disease Soft tissue sarcoma – Life with Disease Marfan’s syndrome – Basic Information Turner’s syndrome – Diagnostics Congenital hypotransferrinaemia – Basic Information X-linked lymphoproliferative syndrome – Trials in Disease Chordoma – Life with Disease Lysosomal storage disorder – Life with Disease Synovial sarcoma metastatic – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Melphalan VHB937 ALG-000184 CICLOPIROX Cefepime Melphalan Flufenamide Afimetoran Besilate Dihydrate ANGIOTENSIN II Epacadostat Gskvx000000017033 Azithromycin Dihydrate Doxecitine Levothyroxine VERCIRNON Cx-039776 Ergocalciferol Carbetocin Pp1815 NADOFARAGENE FIRADENOVEC Lorlatinib More therapies…

    Learn about Your Condition

    Primary adrenal insufficiency Skin angiosarcoma Cutaneous calcification Alpha-1 antitrypsin deficiency Bladder cancer recurrent Cutibacterium acnes infection Insulin resistance Colorectal adenoma Paedophilia Systemic scleroderma Malignant melanoma stage II Gastrointestinal disorder Ocular melanoma Vulvovaginal candidiasis Rectal cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn’s Disease

    Recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Ro7790121
    Austria Belgium Bulgaria Croatia Czechia Denmark +10

  • Study on Rezafungin Levels in Critically Ill Patients with Invasive Candidiasis Undergoing ECMO or RRT

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Candida infection
    • Systemic candida
    Investigated Drugs:
    • Rezafungin Acetate
    Austria

  • Study on IMA203 for Patients with Previously Treated Unresectable or Metastatic Skin Melanoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • AUTOLOGOUS T-CELLS TRANSDUCED WITH THE LENTIVIRAL LV-R11KEA ENCODING T-CELL RECEPTOR TARGETING PATIENT-SPECIFIC TUMOR-ASSOCIATED ANTIGENS
    • Relatlimab
    • Dacarbazine
    France Germany The Netherlands

  • Study on High-Dose Short-Course Antibiotics for Critically Ill Patients with Pneumonia, Intra-Abdominal, or Bloodstream Infections: Ceftriaxone, Linezolid, and Cefotaxime

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Abdominal infection
    • Haematological infection
    • Pneumonia bacterial
    Investigated Drugs:
    • Cefuroxime Axetil
    • Linezolid
    • Sodium
    Belgium The Netherlands

  • Study on Tozorakimab for Adults with Uncontrolled Asthma Using Medium-to-High Dose Inhaled Corticosteroids

    Recruiting

    2 1 1
    Investigated Drugs:
    • Tozorakimab
    • Salbutamol Sulfate
    France Greece Hungary Italy Spain

  • Study of BP CC 001 stem cells from umbilical cord tissue for treating knee cartilage damage

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chondropathy
    Germany
Previous Page
1 … 224 225 226 227 228 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!